Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins

<table><i>Statin-STEMI study.</i> This modified graphic of the Statin-STEMI study, demonstrated the favorable effect of high doses of atorvastatin before primary PCI on the Myocardial Reperfusion Indicators (cTFC, CSTR, and MBG) after procedure in individuals with STEMI.</table>

International Journal of Hypertension

fig9

Figure 9

Figure 9: Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins 